Todd Verdoorn, PhD.

Todd is a neuropharmacologist with more than 20 years experience developing drugs for neurological diseases in large and small pharmaceutical companies. His particular focus has been progressing late-stage preclinical drugs through the IND process and into Phase II clinical trials.